Pre-order Enquiry
Request Free Sample
Global Irritable Bowel Syndrome (IBS) Market Insights and Forecast to 2027
SKU ID : QYR-17927099 | Publishing Date : 06-Apr-2021 | No. of pages : 115
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Irritable Bowel Syndrome (IBS) Market Insights and Forecast to 2027
1 Study Coverage1.1 Irritable Bowel Syndrome (IBS) Product Introduction
1.2 Market by Type
1.2.1 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type
1.4.2 IBS-D Drug
1.4.3 IBS-C Drug
1.2.4 Other
1.3 Market by Application
1.3.1 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Application
1.3.2 Women
1.3.3 Men
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Irritable Bowel Syndrome (IBS) Sales Estimates and Forecasts 2016-2027
2.2 Global Irritable Bowel Syndrome (IBS) Revenue Estimates and Forecasts 2016-2027
2.3 Global Irritable Bowel Syndrome (IBS) Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Irritable Bowel Syndrome (IBS) Regions by Sales
2.4.1 Global Top Irritable Bowel Syndrome (IBS) Regions by Sales (2016-2021)
2.4.2 Global Top Irritable Bowel Syndrome (IBS) Regions by Sales (2022-2027)
2.5 Global Top Irritable Bowel Syndrome (IBS) Regions by Revenue
2.5.1 Global Top Irritable Bowel Syndrome (IBS) Regions by Revenue (2016-2021)
2.5.2 Global Top Irritable Bowel Syndrome (IBS) Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Irritable Bowel Syndrome (IBS) Sales by Manufacturers
3.1.1 Global Top Irritable Bowel Syndrome (IBS) Manufacturers by Sales (2016-2021)
3.1.2 Global Top Irritable Bowel Syndrome (IBS) Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome (IBS) Sales in 2020
3.2 Global Irritable Bowel Syndrome (IBS) Revenue by Manufacturers
3.2.1 Global Top Irritable Bowel Syndrome (IBS) Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Irritable Bowel Syndrome (IBS) Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome (IBS) Revenue in 2020
3.3 Global Irritable Bowel Syndrome (IBS) Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Irritable Bowel Syndrome (IBS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Irritable Bowel Syndrome (IBS) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Irritable Bowel Syndrome (IBS) Sales by Type
4.1.1 Global Irritable Bowel Syndrome (IBS) Historical Sales by Type (2016-2021)
4.1.2 Global Irritable Bowel Syndrome (IBS) Forecasted Sales by Type (2022-2027)
4.1.3 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2027)
4.2 Global Irritable Bowel Syndrome (IBS) Revenue by Type
4.2.1 Global Irritable Bowel Syndrome (IBS) Historical Revenue by Type (2016-2021)
4.2.2 Global Irritable Bowel Syndrome (IBS) Forecasted Revenue by Type (2022-2027)
4.2.3 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2016-2027)
4.3 Global Irritable Bowel Syndrome (IBS) Price by Type
4.3.1 Global Irritable Bowel Syndrome (IBS) Price by Type (2016-2021)
4.3.2 Global Irritable Bowel Syndrome (IBS) Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Irritable Bowel Syndrome (IBS) Sales by Application
5.1.1 Global Irritable Bowel Syndrome (IBS) Historical Sales by Application (2016-2021)
5.1.2 Global Irritable Bowel Syndrome (IBS) Forecasted Sales by Application (2022-2027)
5.1.3 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2027)
5.2 Global Irritable Bowel Syndrome (IBS) Revenue by Application
5.2.1 Global Irritable Bowel Syndrome (IBS) Historical Revenue by Application (2016-2021)
5.2.2 Global Irritable Bowel Syndrome (IBS) Forecasted Revenue by Application (2022-2027)
5.2.3 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2016-2027)
5.3 Global Irritable Bowel Syndrome (IBS) Price by Application
5.3.1 Global Irritable Bowel Syndrome (IBS) Price by Application (2016-2021)
5.3.2 Global Irritable Bowel Syndrome (IBS) Price Forecast by Application (2022-2027)
6 North America
6.1 North America Irritable Bowel Syndrome (IBS) Market Size by Type
6.1.1 North America Irritable Bowel Syndrome (IBS) Sales by Type (2016-2027)
6.1.2 North America Irritable Bowel Syndrome (IBS) Revenue by Type (2016-2027)
6.2 North America Irritable Bowel Syndrome (IBS) Market Size by Application
6.2.1 North America Irritable Bowel Syndrome (IBS) Sales by Application (2016-2027)
6.2.2 North America Irritable Bowel Syndrome (IBS) Revenue by Application (2016-2027)
6.3 North America Irritable Bowel Syndrome (IBS) Market Size by Country
6.3.1 North America Irritable Bowel Syndrome (IBS) Sales by Country (2016-2027)
6.3.2 North America Irritable Bowel Syndrome (IBS) Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Type
7.1.1 Europe Irritable Bowel Syndrome (IBS) Sales by Type (2017-2027)
7.1.2 Europe Irritable Bowel Syndrome (IBS) Revenue by Type (2017-2027)
7.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Application
7.2.1 Europe Irritable Bowel Syndrome (IBS) Sales by Application (2017-2027)
7.2.2 Europe Irritable Bowel Syndrome (IBS) Revenue by Application (2017-2027)
7.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Country
7.3.1 Europe Irritable Bowel Syndrome (IBS) Sales by Country (2017-2027)
7.3.2 Europe Irritable Bowel Syndrome (IBS) Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Irritable Bowel Syndrome (IBS) Market Size by Type
8.1.1 Asia Pacific Irritable Bowel Syndrome (IBS) Sales by Type (2018-2027)
8.1.2 Asia Pacific Irritable Bowel Syndrome (IBS) Revenue by Type (2018-2027)
8.2 Asia Pacific Irritable Bowel Syndrome (IBS) Market Size by Application
8.2.1 Asia Pacific Irritable Bowel Syndrome (IBS) Sales by Application (2018-2027)
8.2.2 Asia Pacific Irritable Bowel Syndrome (IBS) Revenue by Application (2018-2027)
8.3 Asia Pacific Irritable Bowel Syndrome (IBS) Market Size by Region
8.3.1 Asia Pacific Irritable Bowel Syndrome (IBS) Sales by Region (2018-2027)
8.3.2 Asia Pacific Irritable Bowel Syndrome (IBS) Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Irritable Bowel Syndrome (IBS) Market Size by Type
9.1.1 Latin America Irritable Bowel Syndrome (IBS) Sales by Type (2019-2027)
9.1.2 Latin America Irritable Bowel Syndrome (IBS) Revenue by Type (2019-2027)
9.2 Latin America Irritable Bowel Syndrome (IBS) Market Size by Application
9.2.1 Latin America Irritable Bowel Syndrome (IBS) Sales by Application (2019-2027)
9.2.2 Latin America Irritable Bowel Syndrome (IBS) Revenue by Application (2019-2027)
9.3 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country
9.3.1 Latin America Irritable Bowel Syndrome (IBS) Sales by Country (2019-2027)
9.3.2 Latin America Irritable Bowel Syndrome (IBS) Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Size by Type
6.1.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Type (2016-2027)
6.1.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Type (2016-2027)
6.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Size by Application
6.2.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Application (2016-2027)
6.2.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Application (2016-2027)
6.3 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Size by Country
6.3.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Country (2016-2027)
6.3.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 Bausch Health
11.1.1 Bausch Health Corporation Information
11.1.2 Bausch Health Overview
11.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Bausch Health Irritable Bowel Syndrome (IBS) Product Description
11.1.5 Bausch Health Related Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Overview
11.2.3 Allergan Irritable Bowel Syndrome (IBS) Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Allergan Irritable Bowel Syndrome (IBS) Product Description
11.2.5 Allergan Related Developments
11.3 Takeda
11.3.1 Takeda Corporation Information
11.3.2 Takeda Overview
11.3.3 Takeda Irritable Bowel Syndrome (IBS) Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Takeda Irritable Bowel Syndrome (IBS) Product Description
11.3.5 Takeda Related Developments
11.4 Sucampo Pharmaceuticals (Mallinckrodt)
11.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Corporation Information
11.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Overview
11.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Description
11.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Related Developments
11.5 Sebela Pharmaceuticals Inc
11.5.1 Sebela Pharmaceuticals Inc Corporation Information
11.5.2 Sebela Pharmaceuticals Inc Overview
11.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Description
11.5.5 Sebela Pharmaceuticals Inc Related Developments
11.6 Astellas Pharmaceuticals
11.6.1 Astellas Pharmaceuticals Corporation Information
11.6.2 Astellas Pharmaceuticals Overview
11.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Description
11.6.5 Astellas Pharmaceuticals Related Developments
11.1 Bausch Health
11.1.1 Bausch Health Corporation Information
11.1.2 Bausch Health Overview
11.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Bausch Health Irritable Bowel Syndrome (IBS) Product Description
11.1.5 Bausch Health Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Irritable Bowel Syndrome (IBS) Value Chain Analysis
12.2 Irritable Bowel Syndrome (IBS) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Irritable Bowel Syndrome (IBS) Production Mode & Process
12.4 Irritable Bowel Syndrome (IBS) Sales and Marketing
12.4.1 Irritable Bowel Syndrome (IBS) Sales Channels
12.4.2 Irritable Bowel Syndrome (IBS) Distributors
12.5 Irritable Bowel Syndrome (IBS) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Irritable Bowel Syndrome (IBS) Industry Trends
13.2 Irritable Bowel Syndrome (IBS) Market Drivers
13.3 Irritable Bowel Syndrome (IBS) Market Challenges
13.4 Irritable Bowel Syndrome (IBS) Market Restraints
14 Key Findings in The Global Irritable Bowel Syndrome (IBS) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Figures, Tables and Charts Available in Global Irritable Bowel Syndrome (IBS) Market Insights and Forecast to 2027
List of TablesTable 1. Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of IBS-D Drug
Table 3. Major Manufacturers of IBS-C Drug
Table 4. Major Manufacturers of Other
Table 5. Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Irritable Bowel Syndrome (IBS) Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Irritable Bowel Syndrome (IBS) Sales by Region (2016-2021) & (Million Units)
Table 8. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Region (2016-2021)
Table 9. Global Irritable Bowel Syndrome (IBS) Sales by Region (2016-2021) & (Million Units)
Table 10. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Region (2022-2027)
Table 11. Global Irritable Bowel Syndrome (IBS) Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Region (2016-2021)
Table 13. Global Irritable Bowel Syndrome (IBS) Revenue by Region (2022-2027) & (US$ Million)
Table 14. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Region (2022-2027)
Table 15. Global Irritable Bowel Syndrome (IBS) Sales by Manufacturers (2016-2021) & (Million Units)
Table 16. Global Irritable Bowel Syndrome (IBS) Sales Share by Manufacturers (2016-2021)
Table 17. Global Irritable Bowel Syndrome (IBS) Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 18. Global Irritable Bowel Syndrome (IBS) Revenue Share by Manufacturers (2016-2021)
Table 19. Irritable Bowel Syndrome (IBS) Price by Manufacturers 2016-2021 (USD/K Units)
Table 20. Global Irritable Bowel Syndrome (IBS) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Irritable Bowel Syndrome (IBS) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome (IBS) as of 2020)
Table 22. Irritable Bowel Syndrome (IBS) Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Irritable Bowel Syndrome (IBS) Product Offered
Table 24. Date of Manufacturers Enter into Irritable Bowel Syndrome (IBS) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Irritable Bowel Syndrome (IBS) Sales by Type (2016-2021) & (Million Units)
Table 27. Global Irritable Bowel Syndrome (IBS) Sales by Type (2022-2027) & (Million Units)
Table 28. Global Irritable Bowel Syndrome (IBS) Sales Share by Type (2016-2021)
Table 29. Global Irritable Bowel Syndrome (IBS) Sales Share by Type (2022-2027)
Table 30. Global Irritable Bowel Syndrome (IBS) Revenue by Type (2016-2021) & (US$ Million)
Table 31. Global Irritable Bowel Syndrome (IBS) Revenue by Type (2022-2027) & (US$ Million)
Table 32. Global Irritable Bowel Syndrome (IBS) Revenue Share by Type (2016-2021)
Table 33. Global Irritable Bowel Syndrome (IBS) Revenue Share by Type (2022-2027)
Table 34. Irritable Bowel Syndrome (IBS) Price by Type (2016-2021) & (USD/K Units)
Table 35. Global Irritable Bowel Syndrome (IBS) Price Forecast by Type (2022-2027) & (USD/K Units)
Table 36. Global Irritable Bowel Syndrome (IBS) Sales by Application (2016-2021) & (Million Units)
Table 37. Global Irritable Bowel Syndrome (IBS) Sales by Application (2022-2027) & (Million Units)
Table 38. Global Irritable Bowel Syndrome (IBS) Sales Share by Application (2016-2021)
Table 39. Global Irritable Bowel Syndrome (IBS) Sales Share by Application (2022-2027)
Table 40. Global Irritable Bowel Syndrome (IBS) Revenue by Application (2016-2021) & (US$ Million)
Table 41. Global Irritable Bowel Syndrome (IBS) Revenue by Application (2022-2027) & (US$ Million)
Table 42. Global Irritable Bowel Syndrome (IBS) Revenue Share by Application (2016-2021)
Table 43. Global Irritable Bowel Syndrome (IBS) Revenue Share by Application (2022-2027)
Table 44. Irritable Bowel Syndrome (IBS) Price by Application (2016-2021) & (USD/K Units)
Table 45. Global Irritable Bowel Syndrome (IBS) Price Forecast by Application (2022-2027) & (USD/K Units)
Table 46. North America Irritable Bowel Syndrome (IBS) Sales by Type (2016-2021) & (Million Units)
Table 47. North America Irritable Bowel Syndrome (IBS) Sales by Type (2022-2027) & (Million Units)
Table 48. North America Irritable Bowel Syndrome (IBS) Revenue by Type (2016-2021) & (US$ Million)
Table 49. North America Irritable Bowel Syndrome (IBS) Revenue by Type (2022-2027) & (US$ Million)
Table 50. North America Irritable Bowel Syndrome (IBS) Sales by Application (2016-2021) & (Million Units)
Table 51. North America Irritable Bowel Syndrome (IBS) Sales by Application (2022-2027) & (Million Units)
Table 52. North America Irritable Bowel Syndrome (IBS) Revenue by Application (2016-2021) & (US$ Million)
Table 53. North America Irritable Bowel Syndrome (IBS) Revenue by Application (2022-2027) & (US$ Million)
Table 54. North America Irritable Bowel Syndrome (IBS) Sales by Country (2016-2021) & (Million Units)
Table 55. North America Irritable Bowel Syndrome (IBS) Sales by Country (2022-2027) & (Million Units)
Table 56. North America Irritable Bowel Syndrome (IBS) Revenue by Country (2016-2021) & (US$ Million)
Table 57. North America Irritable Bowel Syndrome (IBS) Revenue by Country (2022-2027) & (US$ Million)
Table 58. Europe Irritable Bowel Syndrome (IBS) Sales by Type (2016-2021) & (Million Units)
Table 59. Europe Irritable Bowel Syndrome (IBS) Sales by Type (2022-2027) & (Million Units)
Table 60. Europe Irritable Bowel Syndrome (IBS) Revenue by Type (2016-2021) & (US$ Million)
Table 61. Europe Irritable Bowel Syndrome (IBS) Revenue by Type (2022-2027) & (US$ Million)
Table 62. Europe Irritable Bowel Syndrome (IBS) Sales by Application (2016-2021) & (Million Units)
Table 63. Europe Irritable Bowel Syndrome (IBS) Sales by Application (2022-2027) & (Million Units)
Table 64. Europe Irritable Bowel Syndrome (IBS) Revenue by Application (2016-2021) & (US$ Million)
Table 65. Europe Irritable Bowel Syndrome (IBS) Revenue by Application (2022-2027) & (US$ Million)
Table 66. Europe Irritable Bowel Syndrome (IBS) Sales by Country (2016-2021) & (Million Units)
Table 67. Europe Irritable Bowel Syndrome (IBS) Sales by Country (2022-2027) & (Million Units)
Table 68. Europe Irritable Bowel Syndrome (IBS) Revenue by Country (2016-2021) & (US$ Million)
Table 69. Europe Irritable Bowel Syndrome (IBS) Revenue by Country (2022-2027) & (US$ Million)
Table 70. Asia Pacific Irritable Bowel Syndrome (IBS) Sales by Type (2016-2021) & (Million Units)
Table 71. Asia Pacific Irritable Bowel Syndrome (IBS) Sales by Type (2022-2027) & (Million Units)
Table 72. Asia Pacific Irritable Bowel Syndrome (IBS) Revenue by Type (2016-2021) & (US$ Million)
Table 73. Asia Pacific Irritable Bowel Syndrome (IBS) Revenue by Type (2022-2027) & (US$ Million)
Table 74. Asia Pacific Irritable Bowel Syndrome (IBS) Sales by Application (2016-2021) & (Million Units)
Table 75. Asia Pacific Irritable Bowel Syndrome (IBS) Sales by Application (2022-2027) & (Million Units)
Table 76. Asia Pacific Irritable Bowel Syndrome (IBS) Revenue by Application (2016-2021) & (US$ Million)
Table 77. Asia Pacific Irritable Bowel Syndrome (IBS) Revenue by Application (2022-2027) & (US$ Million)
Table 78. Asia Pacific Irritable Bowel Syndrome (IBS) Sales by Region (2016-2021) & (Million Units)
Table 79. Asia Pacific Irritable Bowel Syndrome (IBS) Sales by Region (2022-2027) & (Million Units)
Table 80. Asia Pacific Irritable Bowel Syndrome (IBS) Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Irritable Bowel Syndrome (IBS) Revenue by Region (2022-2027) & (US$ Million)
Table 82. Latin America Irritable Bowel Syndrome (IBS) Sales by Type (2016-2021) & (Million Units)
Table 83. Latin America Irritable Bowel Syndrome (IBS) Sales by Type (2022-2027) & (Million Units)
Table 84. Latin America Irritable Bowel Syndrome (IBS) Revenue by Type (2016-2021) & (US$ Million)
Table 85. Latin America Irritable Bowel Syndrome (IBS) Revenue by Type (2022-2027) & (US$ Million)
Table 86. Latin America Irritable Bowel Syndrome (IBS) Sales by Application (2016-2021) & (Million Units)
Table 87. Latin America Irritable Bowel Syndrome (IBS) Sales by Application (2022-2027) & (Million Units)
Table 88. Latin America Irritable Bowel Syndrome (IBS) Revenue by Application (2016-2021) & (US$ Million)
Table 89. Latin America Irritable Bowel Syndrome (IBS) Revenue by Application (2022-2027) & (US$ Million)
Table 90. Latin America Irritable Bowel Syndrome (IBS) Sales by Country (2016-2021) & (Million Units)
Table 91. Latin America Irritable Bowel Syndrome (IBS) Sales by Country (2022-2027) & (Million Units)
Table 92. Latin America Irritable Bowel Syndrome (IBS) Revenue by Country (2016-2021) & (US$ Million)
Table 93. Latin America Irritable Bowel Syndrome (IBS) Revenue by Country (2022-2027) & (US$ Million)
Table 94. Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Type (2016-2021) & (Million Units)
Table 95. Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Type (2022-2027) & (Million Units)
Table 96. Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Type (2016-2021) & (US$ Million)
Table 97. Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Type (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Application (2016-2021) & (Million Units)
Table 99. Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Application (2022-2027) & (Million Units)
Table 100. Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Application (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Application (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Country (2016-2021) & (Million Units)
Table 103. Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Country (2022-2027) & (Million Units)
Table 104. Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Country (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Country (2022-2027) & (US$ Million)
Table 106. Bausch Health Corporation Information
Table 107. Bausch Health Description and Major Businesses
Table 108. Bausch Health Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 109. Bausch Health Irritable Bowel Syndrome (IBS) Product
Table 110. Bausch Health Recent Developments
Table 111. Allergan Corporation Information
Table 112. Allergan Description and Major Businesses
Table 113. Allergan Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 114. Allergan Irritable Bowel Syndrome (IBS) Product
Table 115. Allergan Recent Developments
Table 116. Takeda Corporation Information
Table 117. Takeda Description and Major Businesses
Table 118. Takeda Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 119. Takeda Irritable Bowel Syndrome (IBS) Product
Table 120. Takeda Recent Developments
Table 121. Sucampo Pharmaceuticals (Mallinckrodt) Corporation Information
Table 122. Sucampo Pharmaceuticals (Mallinckrodt) Description and Major Businesses
Table 123. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 124. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product
Table 125. Sucampo Pharmaceuticals (Mallinckrodt) Recent Developments
Table 126. Sebela Pharmaceuticals Inc Corporation Information
Table 127. Sebela Pharmaceuticals Inc Description and Major Businesses
Table 128. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 129. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product
Table 130. Sebela Pharmaceuticals Inc Recent Developments
Table 131. Astellas Pharmaceuticals Corporation Information
Table 132. Astellas Pharmaceuticals Description and Major Businesses
Table 133. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 134. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product
Table 135. Astellas Pharmaceuticals Recent Developments
Table 136. Key Raw Materials Lists
Table 137. Raw Materials Key Suppliers Lists
Table 138. Irritable Bowel Syndrome (IBS) Distributors List
Table 139. Irritable Bowel Syndrome (IBS) Customers List
Table 140. Irritable Bowel Syndrome (IBS) Market Trends
Table 141. Irritable Bowel Syndrome (IBS) Market Drivers
Table 142. Irritable Bowel Syndrome (IBS) Market Challenges
Table 143. Irritable Bowel Syndrome (IBS) Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Irritable Bowel Syndrome (IBS) Product Picture
Figure 2. Global Irritable Bowel Syndrome (IBS) Market Share by Type in 2020 & 2027
Figure 3. IBS-D Drug Product Picture
Figure 4. IBS-C Drug Product Picture
Figure 5. Other Product Picture
Figure 6. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Application in 2020 & 2027
Figure 7. Women
Figure 8. Men
Figure 9. Irritable Bowel Syndrome (IBS) Report Years Considered
Figure 10. Global Irritable Bowel Syndrome (IBS) Sales 2016-2027 (Million Units)
Figure 11. Global Irritable Bowel Syndrome (IBS) Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Irritable Bowel Syndrome (IBS) Revenue 2016-2027 (US$ Million)
Figure 13. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Region (2016-2021)
Figure 15. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Region (2022-2027)
Figure 16. North America Irritable Bowel Syndrome (IBS) Sales YoY (2016-2027) & (Million Units)
Figure 17. North America Irritable Bowel Syndrome (IBS) Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Irritable Bowel Syndrome (IBS) Sales YoY (2016-2027) & (Million Units)
Figure 19. Europe Irritable Bowel Syndrome (IBS) Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Irritable Bowel Syndrome (IBS) Sales YoY (2016-2027) & (Million Units)
Figure 21. Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Irritable Bowel Syndrome (IBS) Sales YoY (2016-2027) & (Million Units)
Figure 23. Latin America Irritable Bowel Syndrome (IBS) Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Irritable Bowel Syndrome (IBS) Sales YoY (2016-2027) & (Million Units)
Figure 25. Middle East & Africa Irritable Bowel Syndrome (IBS) Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Irritable Bowel Syndrome (IBS) Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Irritable Bowel Syndrome (IBS) Revenue in 2020
Figure 28. Irritable Bowel Syndrome (IBS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2027)
Figure 30. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2016-2027)
Figure 31. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2027)
Figure 32. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2016-2027)
Figure 33. North America Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2027)
Figure 34. North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2016-2027)
Figure 35. North America Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2027)
Figure 36. North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2016-2027)
Figure 37. North America Irritable Bowel Syndrome (IBS) Sales Share by Country (2016-2027)
Figure 38. North America Irritable Bowel Syndrome (IBS) Revenue Share by Country (2016-2027)
Figure 39. U.S. Irritable Bowel Syndrome (IBS) Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Irritable Bowel Syndrome (IBS) Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2027)
Figure 42. Europe Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2016-2027)
Figure 43. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2027)
Figure 44. Europe Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2016-2027)
Figure 45. Europe Irritable Bowel Syndrome (IBS) Sales Share by Country (2016-2027)
Figure 46. Europe Irritable Bowel Syndrome (IBS) Revenue Share by Country (2016-2027)
Figure 47. Germany Irritable Bowel Syndrome (IBS) Revenue (2016-2027) & (US$ Million)
Figure 48. France Irritable Bowel Syndrome (IBS) Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Irritable Bowel Syndrome (IBS) Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Irritable Bowel Syndrome (IBS) Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Irritable Bowel Syndrome (IBS) Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific Irritable Bowel Syndrome (IBS) Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Irritable Bowel Syndrome (IBS) Revenue Share by Region (2016-2027)
Figure 58. China Irritable Bowel Syndrome (IBS) Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Irritable Bowel Syndrome (IBS) Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Irritable Bowel Syndrome (IBS) Revenue (2016-2027) & (US$ Million)
Figure 61. India Irritable Bowel Syndrome (IBS) Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Irritable Bowel Syndrome (IBS) Revenue (2016-2027) & (US$ Million)
Figure 63. Taiwan Irritable Bowel Syndrome (IBS) Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Irritable Bowel Syndrome (IBS) Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Irritable Bowel Syndrome (IBS) Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Irritable Bowel Syndrome (IBS) Revenue (2016-2027) & (US$ Million)
Figure 67. Philippines Irritable Bowel Syndrome (IBS) Revenue (2016-2027) & (US$ Million)
Figure 68. Latin America Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2027)
Figure 69. Latin America Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2016-2027)
Figure 70. Latin America Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2027)
Figure 71. Latin America Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2016-2027)
Figure 72. Latin America Irritable Bowel Syndrome (IBS) Sales Share by Country (2016-2027)
Figure 73. Latin America Irritable Bowel Syndrome (IBS) Revenue Share by Country (2016-2027)
Figure 74. Mexico Irritable Bowel Syndrome (IBS) Revenue (2016-2027) & (US$ Million)
Figure 75. Brazil Irritable Bowel Syndrome (IBS) Revenue (2016-2027) & (US$ Million)
Figure 76. Argentina Irritable Bowel Syndrome (IBS) Revenue (2016-2027) & (US$ Million)
Figure 77. Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Share by Country (2016-2027)
Figure 82. Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Share by Country (2016-2027)
Figure 83. Turkey Irritable Bowel Syndrome (IBS) Revenue (2016-2027) & (US$ Million)
Figure 84. Saudi Arabia Irritable Bowel Syndrome (IBS) Revenue (2016-2027) & (US$ Million)
Figure 85. U.A.E Irritable Bowel Syndrome (IBS) Revenue (2016-2027) & (US$ Million)
Figure 86. Irritable Bowel Syndrome (IBS) Value Chain
Figure 87. Irritable Bowel Syndrome (IBS) Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Keyplayers in Global Irritable Bowel Syndrome (IBS) Market Insights and Forecast to 2027
Bausch HealthAllergan
Takeda
Sucampo Pharmaceuticals (Mallinckrodt)
Sebela Pharmaceuticals Inc
Astellas Pharmaceuticals
